China
Genee Group is a high-tech enterprise established in 2008, with its R&D headquarters in Tianjin and branch offices in Beijing, Shanghai, Chongqing, and Boston. The company focuses on providing intelligent research management solutions for scientific researchers, holding various quality and safety certifications and patents. Genee Group went public on the New Third Board in October 2017, under the stock code 872218.
In 2009, Genee Group launched the industry's first intelligent shared management platform for large laboratory instruments, leveraging cutting-edge Internet and IoT technologies. This marked a significant milestone in the instrument-sharing field. Subsequently, in 2012, the company introduced a platform for secure procurement and management of reagents and materials, integrating mobile internet and IoT technologies to enable full-lifecycle management of laboratory materials, ensuring safety and traceability. Moreover, Genee Group innovatively developed a laboratory safety and environmental monitoring system, incorporating technologies such as big data, IoT, and AI to provide robust security for laboratory environments.
Currently, the company's platforms are utilized by over 300,000 users daily, and its products and services are chosen by more than 200 universities and research institutes nationwide. With a service network covering 28 provinces, municipalities, and autonomous regions, Genee Group has gained industry acclaim for its strong research capabilities and development potential. The company's last notable investment was a CNY4.00M Series B investment by Caitong Asset on 22 April 2016.
With its focus on "research-oriented, customer-first" principles, Genee Group aims to redefine scientific research, making it simpler and safer for researchers, further solidifying its reputation as a leading provider of research solutions.
